Cyclometalated gold(III)‐hydride under oriented external electric fields: a new strategy to modulate its reactivity?

Abstract

AbstractSelected gold complexes have been regarded as promising anti‐cancer agents because they can bind with protein targets containing thiol or selenol moieties, but their clinical applications were hindered by the unbiased binding towards off‐target thiol‐proteins. Recently, a novel gold(III)‐hydride complex (abbreviated as 1) with visible light‐induced thiol reactivity has been reported as potent photo‐activated anticancer agents (Angew. Chem. Int. Ed., 2020, 132, 11139). To explore new strategies to stimuli this potential antitumor drug, the effect of oriented external electric fields (OEEFs) on its geometric structure, electronic properties, and chemical reactivity was systematically investigated. Results reveal that imposing external electric fields along the Au−H bond of 1 can effectively activate this bond, which is conducive to its dissociation and the binding of Au site to potential targets. Hence, this study provides a new OEEF‐strategy to activate this reported gold(III)‐hydride, revealing its potential application in electrochemical therapy. We anticipate this work could promote the development of more electric field‐activated anticancer agents. However, further experimental research should be conducted to verify the conclusions obtained in this work.